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1 Introduction 
1.1 What is nanotechnology? 
The prefix nano derives from the Greek word ‘nanos’ that means dwarf. A nanometer (nm) is a 
unit of measurement equal to one billionth of a meter. For example, a single sheet of paper is 
about 100,000 nanometers thick. Another commonly used example is the thickness of a human 
hair: one nanometer is about 1/80,000 of the diameter of the average human hair. The size of a 
red blood cell is around 7000 nanometers. Clearly nanotechnology refers to things on an 
incredibly small size scale. 
Nobel-prize winner Richard Feynman delivered a lecture in 1959, in which he explored the 
question of whether in the future it would be possible to manipulate matter at atomic level1. 
Feynman was the first one to introduce the idea of nanotechnology. Nanotechnology is the 
study of manipulating matter on an atomic and molecular scale, and generally it deals with 
structures sized between 1 and 100 nanometers in at least one dimension. The term 
nanotechnology defined by the European Patent Office “covers entities with a controlled geometrical 
size of at least one functional component below 100 nanometers in one or more dimensions susceptible of 
making physical, chemical or biological effects available which are intrinsic to that size. It covers 
equipment and methods for controlled analysis, manipulation, processing, fabrication or measurement with 
a precision below 100 nanometers”.2  Because at this size scale the laws of quantum mechanics 
begin to affect the basic properties of matter, atoms and molecules have different properties 
and provide a variety of surprising and interesting uses3, for example, in the field of heat and 
electric conductivity and strength4.  
Nanotechnology has infinite possibilities and huge potential. Nanotechnology today is, for 
example, used in several materials to improve their qualities: the substantial structure of carbon 
nanotubes makes them stronger and lighter than any other composition of material. In 
addition, carbon nanotubes have unique electrical properties and efficient conduction of heat, 
which makes them potentially useful in a wide variety of applications. The somewhat futuristic 
belief of some experts is that nanodevices distributed throughout the brain may permit copying 
of thought patterns and  copy a person’s personality in order to create artificial intelligence. 
 
1 Feynman, 1959. 
2 http://www.epo.org/topics/issues/nanotechnology.html 11.2.2011. 
3 HelsinkiNano loppuraportti, p. 7. 
4 Schellekens 2010, p. 48. 
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1.2 Intellectual property issues related to nanotechnology 
Nanotechnology is an emerging technology and thus interesting intellectual property questions 
arise related to its protection. Characteristic to nanotechnology is its interdisciplinary nature. 
Nanotechnology is a broad multidiscipline science covering aspects of biology, chemistry, 
physics, and other disciplines. The interdisciplinary nature of nanotechnology makes it 
challenging for the patent authorities to examine the patentability of nanotech inventions; the 
difficulty lies in finding all relevant prior art. Typical to nanotechnology is also the fact that the 
building blocks of the technology were patented at the outset. More and more of the patents 
issued in the field of nanotechnology are issued to universities, which is no wonder considering 
the fact that universities conduct most of the basic research. As patentees, universities differ 
from private equities. 
Research and development of nanotechnology requires a huge investment; researchers and 
their financiers need an incentive to continue research and innovation. The potential income 
from patenting and licensing inventions serves this purpose well. Thus one important issue is 
the licensing of nanotechnology, and of course proper protection of the intellectual property 
rights against infringement. 
The special characteristics of nanotechnology in this paper are approached from the European 
and the United States point of view, but the aim is to keep the paper on a generic level and 
address nanotechnology related problems common around the globe.  
2 Patentability of Nanotechnology 
2.1 Discovery or an invention? 
To be patentable, a nanotechnology invention must consist of patentable subject matter. The 
first question raised by nanotechnology is whether some nanotechnology inventions are 
inventions at all, or are they rather scientific discoveries or products of nature. It is globally 
accepted that abstract ideas and “products of nature” or discoveries5 are not patentable6.  
As the U.S. Supreme Court has stated, “phenomena of nature, though just discovered, mental 
processes, and abstract intellectual concepts are not patentable, as they are the basic tools of 
 
5 In the U.S. the term “invention” means invention or discovery (35 U.S.C. 100a), and thus according to the U.S. 
terminology discoveries are patentable. In the EPC the term “discovery” has a similar meaning as the term 
“product of nature” in the U.S., and it is not patentable according to the EPC 2000 Art 52(2). 
6 European legislation EPC 2000 Art. 52. In the U.S. “product of nature” is a judicially created doctrine, see 
Gottschalk v. Benson, 409 U.S. 63, 67 (1972) and Benson, 409 U.S. at 67. Statutory law does not restrict 
patentability subject-matter. 
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scientific and technological work”7. In the U.S., the concepts encompassed by the product of 
nature doctrine have not been clearly defined by the United States Supreme Court or the 
United States Court of Appeals for the Federal Circuit, which has lead to a situation where the 
Patent Office and district courts have been left to determine whether a particular invention is 
properly classified as a product of nature. This has resulted inconsistent rulings, and because of 
the presumption of validity that attaches to issued patents has been significantly discredited, 
this jeopardizes both investments in emerging technologies and incentives to innovate.8 
In the European patent system only inventions can become object of a patent right, and the 
examples of what cannot be regarded as inventions are listed in the EPC. According to article 
52(2) EPC, discoveries, scientific theories and mathematical methods, aesthetic creations, 
schemes, rules and methods for performing mental acts, playing games or doing business, and 
programs for computers and presentations of information are not regarded as inventions. This 
means that a naturally occurring substance or a new found property of such substance can not 
be regarded as an invention. However, it has to be kept in mind that only discoveries as such are 
not patentable, which means that products and processes that arise from the human effort are 
inventions and thus may be patentable. For example, the process for isolating or synthesizing 
naturally occurring substances are patentable inventions, if they also meet the other 
requirements of patentability.9 
Sometimes it is still difficult to distinguish between an unpatentable scientific discovery and a 
patentable invention. Questions like ‘should an obvious practical application of a newly 
discovered natural phenomenon be patentable’ or ‘should a product or process claimed in such 
broad terms that it covers any practical application of a newly discovered natural phenomenon 
be patentable’ arise.10 I agree with Holman on answering both these questions in the negative. 
However, the problem is that it is hard to maintain consistent practice in issuing patents, 
because of the large amount of patent authorities.  
2.2 Patentability requirements 
2.2.1 Novelty 
To be patentable, an invention has to meet a number of requirements: it has to be novel, 
inventive and susceptible of industrial application. These are called the patentability 
requirements. The novelty and inventive step criteria are most discussed in the field of 
nanotechnology. 
 
7 Benson, 409 U.S. at 67 
8 Parasidis 2010, p. 333. 
9 Schellekens 2010, p. 60. 
10 Holman 2007 p. 540. 
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An invention is novel, if it is not a part of the state of the art. To be patentable, it also has to be 
new. The most obvious questions regarding nanotechnology inventions and their novelty are 
size-related. Is size alone enough to confer novelty upon an invention? Could prior art that does 
not specifically refer to nano size anticipate a nano-scale invention? If the prior art refers only to 
the size scale of micro or larger, the nano-scale equivalent is generally not anticipated, for an 
invention is only anticipated if it has been described completely in the prior art. The Technical 
Board of Appeal addressed the issue of size in Orica Australia/BASF case11 as follows: 
Orica’s patent concerned addition polymer particles that can be stably dispersed in 
liquids. The particles are less than 100 nm and can be dispersed because of their core-
sheath structure. BASF sought revocation of the patent inter alia for the lack of novelty. 
It elicited a prior US patent about dispersions for the preparation of high gloss coatings. 
The particle size in this patent was limited to a minimum of 111 nm. The TBA found 
no implicit disclosure of particle sizes of between 10 and 100nm and upheld Orica’s 
patent. 
Therefore, little or no problems are to be expected, if the ranges mentioned in a patent and the 
prior art are disjunctive.12  
Another issue to discuss is what happens in cases where the ranges mentioned in a patent about 
a nano-scale invention overlap with those mentioned in the existing prior art. The issue was 
addressed in Smithkline Beecham Biologicals/Wyeth13. The invention in this case concerned the 
adjuvant qualities of a lipid in a vaccine. If an adjuvant substance in a vaccine is combined with 
an effective substance it reinforces the latter’s effectiveness. According to the patent, the 
adjuvant effect of the lipid in this case can be improved by reducing its particle size. The patent 
in question describes experiments that empirically demonstrate the improvement in 
effectiveness at smaller particle sizes, but the reason why this effect occurs is not given. A range 
for the particle size mentioned in prior art documents is 80–500 nm, while the patent indicates 
a partially overlapping range of 60–120 nm. In consideration whether this prior art document 
destroyed the novelty of the invention or not, the Technical Board of Appeal (TBA) formulated 
as its criterion whether a person ordinarily skilled in the art (POSITA) would seriously 
contemplate applying the technical teaching of the prior art document in the range of overlap. 
In this case, the TBA found based on certain circumstances14, that the overlap was not novelty 
defeating. The patent office scrutinizes whether the prior art document seriously contemplates 
the application of the invention in the overlapping part of the range. It has allowed claiming an 
 
11 T0547/99. 
12 Schellekens 2010, p. 51-54. See also Kallinger et al. 2008, p. 99–100. 
13 T0552/00. 
14 The overlap in this case represented only 10 % of the broad range of prior art; the prior art did not indicate any 
preferred size-related sub-range of the particles and the POSITA would probably end up with particles not in the 
size range of the patent. 
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overlapping range in various cases, which raises the question, whether this practice is the first 
step in creating a patent thicket.15 
In cases when the prior art does not refer to size, it might destroy the novelty of a nano-scale 
invention, assuming that it contains an enabling disclosure. A nano-scale invention may still be 
novel despite of the fact that it is covered by the terms of a prior art document, if the POSITA 
cannot practice the invention at the nano scale without knowledge of the claimed invention or 
engaging in inventive activity. Nanotechnology is still a nascent and rather uncharted 
technology and the knowledge concerning it is constantly growing, thus non-size-related prior 
art may become ever more enabling prior art. 
In the United States, the §102 of the Patent Act16 precludes obtaining or enforcing patents 
covering an invention previously known or used by others. This paragraph pertains to novelty. 
If a printed prior art reference discloses within its four corners all aspects of a subsequently 
claimed invention, the reference anticipates the claimed invention. For example, in a patent 
application concerning forming self-aligned nano-electrodes17, the applicant was able to 
overcome an anticipatory reference by demonstrating that it failed to clearly disclose one of the 
claimed elements, a transistor.18 
2.2.2 Inventive step 
Besides novelty, an invention must also involve an inventive step in order to be patentable. In 
other words, the invention must not be obvious to the POSITA, having regard to the state of 
the art. In nanotechnology inventions, mere downsizing is not necessarily enough to reach the 
requirements of an inventive step. In many fields downsizing can be considered as an obvious 
measure to take. One way to confer inventiveness on a nano-scale invention is the use of other 
processes to arrive at the nano-scale products. If the processes needed to produce nano-scale 
products are different from the processes used with bigger products, and those processes are not 
obvious to the POSITA, that may constitute an inventive step. Inventiveness can also be 
derived from other sources, such as a new unexpected function at the nano scale that solves a 
problem stated in the patent. Another way for nano-scale inventions to acquire inventiveness is 
that prejudice has to be overcome in order to arrive at a nano-scale invention. According to 
EPO, a prejudice is ‘‘a widely held but incorrect opinion of a technical fact’’19. The idea of 
 
15 Schellekens 2010, p. 51-54. 
16 35 U.S.C §102 
17 U.S. Patent No. 7,312,155 (Filed Apr. 7, 2004, issued Dec. 25, 2007). Available at http://www.patentstorm.us/ 
patents/7312155.html. 
18 Troilo 2005, p. 37. See also Williamson & Carpenter 2010, p. 134. 
19 Schellekens 2010, p. 56. 
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prejudice is very strictly applied and it will become more difficult to use as  knowledge of 
nanotechnology develops further.20 
In the U.S. the required inventiveness of the patentable invention is expressed in 35 U.S.C. § 
103. A patent  may not be obtained, “if the differences between the subject matter sought to be 
patented and the prior art are such that the subject matter as a whole would have been obvious 
at the time the invention was made to a person having ordinary skill in the art to which said 
subject matter pertains”21. The USPTO uses guidelines based on two U.S. Supreme Court 
decisions in order to determine whether an invention is obvious. The first case, Graham v. John 
Deere Co., is from the year 1966. The Supreme Court established four factors for determining 
obviousness: 1) the scope and content of the relevant prior art; 2) the differences between the 
prior art and the claims at issue; 3) the level of ordinary skill in the pertinent art; and 4) 
secondary considerations such as commercial success, long felt but unsolved needs, and failure 
of others. Based on these four factors, the Court of Appeals for the Federal Circuit used the 
TSM test22 for years. Forty years later the Supreme Court again addressed the issue of 
obviousness in KSR Int'l Co. v. Teleflex, Inc. The Court found that the TSM test was rigid, and 
while it didn’t overrule the test, it stated that the TSM test is only one of many tests to 
determine obviousness. The Court found that a POSITA is also a person of ordinary creativity 
and thus in many cases where “familiar items may have obvious uses beyond their primary 
purposes - [and the POSITA]- will be able to fit the teachings of multiple patents together like 
pieces of a puzzle”.23 
2.2.3 Industrial applicability 
According to the European Patent Convention, an invention must be industrially applicable in 
order to be patentable24. An invention is considered as susceptible of industrial application if it 
can be made or used in any kind of industry, including agriculture. This however does not 
mean that industrial applicability requires  ability to make a product for the public at large. 
Basic materials may find application in industry through having a use as research tools. It has to 
be noted that this kind of research tool must, in order to be patentable, have a concrete use as a 
research instrument without the necessity to engage in further research. Another issue 
concerning nanotechnology inventions is that it is sometimes not yet possible to produce 
nanoscale substances in large amounts. That may cast doubt over the industrial applicability of 
a patent on a nano-scale substance, for it is difficult to build an industry on tiny quantities of a 
 
20 Schellekens 2010, p. 54–56. See also Kallinger et al. 2008, p. 100–101. 
21 35 U.S.C. § 103(a) 
22 The TSM test held that obviousness rejections needed some evidence of teaching, suggestion, or motivation to 
combine the relevant prior art. 
23 Williamson & Carpenter 2010, p. 132-133. 
24 EPC Art. 52 and 57. 
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substance. For example, the production of carbon nanotubes at an industrial scale is still not 
completely solved. Distinctive to nanotechnology due to the size scale, is also the fact that it is 
still difficult to verify that nanotech inventions work as claimed by the patentee. Instruments to 
measure effects on a nano scale and even metrologies are often lacking. The disclosure of the 
invention has an important role as it has to be elaborate enough to convince the POSITA that 
the invention works as claimed. If the invention doesn’t work, it has generally no practical use 
and therefore does not meet the requirement of industrial applicability.25 
The requirement of industrial applicability is similar to the U.S. term of utility26. The invention 
defined by the claims of the patent has to have utility, which means it has to be operative and 
function for its intended purpose. While the utility requirement is not usually an issue in 
traditional inventions such as mechanical or electrical applications, it may pose a problem in an 
emerging field like nanotechnology. In emerging technologies the utility of an invention may 
not always be known at the time of conception or reduction to practice. In the interdisciplinary 
field of nanotechnology it is difficult to determine a good balance of claims in a patent 
application; claiming incredible uses of the invention may lead to the patent being denied on 
lack of utility and on the other hand unnecessarily limiting the claims not to cover anticipated 
improvements may render a patent useless.27 
As previously stated, special characteristics in nanotechnology are its interdisciplinary nature 
and the fact that the technology is still in its infancy. The utility of the new inventions may not 
be known at the time of conception, which poses a challenge in patenting nanotechnology. 
Partly due to the lack of sufficient knowledge and partly due to companies intellectual property 
strategies, nanotechnology patents are broadly claimed; a “land-grab” mentality predominates in 
nanotechnology. These and other issues related to nanotechnology inventions are addressed in 
the next chapter. 
3 Operational environment of nanotechnology patenting 
3.1 Operational framework of nanotechnology patents 
Nanotechnology is a branch of technology at its infancy and it typically requires high expertise 
and funding. It is not possible to do nano-scale research without requisite equipment and 
laboratory facilities. Although private corporations invest in nanotechnology research and 
patenting as well, unique to nanotechnology patents is that they are held in large proportion by 
 
25 Schellekens 2010, p. 56–58. 
26 It has to be noted, that the requirements are not congruent. The European patent law does not consider utility 
as a patentability criterion, which can be read in the decision T 0388/04.  
27 Troilo 2005, p. 37–38 and Halluin & Westin 2004, p. 235–236. 
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universities28. The amount of university filings in EPO applications has risen 600 % since the 
1980s, and in nanotechnology and the life sciences universities file up to 50 % of all patent 
applications29. 
Universities collaborate with companies and industry. While the inventions resulted in 
academic research may not yet have commercial or industrial use themselves, private companies 
can carry on developing them into industrially applicable products. In addition, universities 
have top know-how and the advantage of research exemption30 at their use. Private corporations 
have therefore a good reason to fund academic research. 
Nanotechnology has grown explosively under the last years, and much of that growth is funded 
by government grants. Industry is another significant financier, for it sponsors certain research 
agreements.31 Nanotechnological research is carried out in various universities throughout the 
world. As an emerging technology it offers scientists many interesting research subjects and 
huge potential for scientific breakthroughs.  
Over the last decades the universities’ patenting activity has increased. The two main 
elements that lead to this development are the emergence of new technologies and the 
adoption of the Bayh-Dole Act in the U.S. in 198032.  
The Bayh-Dole Act, also known as University and Small Business Patent Procedures 
Act, gives U.S. universities, small businesses and non-profits intellectual property 
control of their inventions and other intellectual property that results from federal 
government funding. The Bayh-Dole Act encourages universities to collaborate with 
industry to promote the development and commercialization of the inventions made at 
universities using federal research funding. Universities have the right to elect title to 
federally funded inventions, and the obligation to file for patents on these inventions 
they elect to own.33 The Act has said to have greatly influenced Europe’s view on 
universities’ obtaining of patents and some countries in Europe even have similar 
legislation in force today.34 
Research universities engage in the transfer of technology inter alia to facilitate the 
commercialization of university discoveries for the public good, to forge closer ties to 
 
28 Lemley 2005, p. 615. 
29 LaFlame 2010, p. 626. 
30 The research exemption excludes certain uses of patented subject matter from their ability to infringe a patent. 
However, the scope of the research exemption differs within several EPC jurisdictions. 
31 Shaddox 2006, p. 166. 
32 LaFlame 2010, p. 625–626. 
33 Berneman & Denis 2002, p. 228–229. 
34 LaFlame 2010, p. 626. 
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industry and to promote economic growth35. The above said and the fact that academic 
patenting could mean potential new jobs in the management of university intellectual 
property are used as justification for academic patenting and regional governments’ 
support to it36.37  
3.2 Patenting building blocks 
Partly due to legislation changes, and partly due to the increased magnitude of intellectual 
property rights around the world, patent applications are filed earlier and more often than ever. 
The case with a new technology like nanotechnology is that the basic ideas, the building blocks 
of nanotechnology, are patented at the outset38.  
Universities have patented building blocks of nanotechnology due to their role in basic 
research. Out of ten foundational nanotechnology inventions identified by Lemley39, seven are 
owned by universities.40 This is possible because universities still probably have the best 
requisites to do fundamental research on new technologies. 
For one reason or another, most of the so called enabling technologies of the twentieth century, 
the computer, software, the Internet and biotechnology, were not patented from the very 
beginning of their rise. The core building blocks of these technologies ended up in the public 
domain through policy decision, shortsightedness, personal belief, government regulation or 
some other reason. In nanotechnology, on the contrary, both universities and companies are 
patenting early and often. Many of the most basic ideas in nanotechnology are already 
patented; patents have issued for example on carbon nanotubes, semiconducting nanocrystals, 
atomic force microscopes and a method of making self-assembling nanolayer. These however 
are not the only patented building blocks and probably more basic ideas in nanotechnology will 
end up patented. Patent applications can sometimes spend long times in the patent office, and 
because many of these applications will never be published, it is impossible to tell, which 
currently unpatented technologies will ultimately be patented.41 
 
35 Berneman & Denis 2002, p. 227. 
36 LaFlame 2010, p. 626. 
37 Academic patenting has also faced criticism: according to LaFlame some scholars see that fostering academic 
patents might lead to a lower "quality" of these patents and that the academic research might shift towards more 
“applied” science due to the incentives created by this fostering 
38 Lemley 2005, p. 605. 
39Lemley lists patents on carbon nanotubes (3), semiconducting nanocrystals (2), light-emitting nanocrystals, metal 
oxide nanorods, atomic force microscopes, a method of making a self-assembling nanolayer, and a method of 
producing nanotubes through chemical vapor deposition. 
40 Lemley 2005, p. 614–616. 
41 Lemley 2005, p. 606–615. 
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Only a few of the basic building blocks are unpatented. Buckminsterfullerene42 is probably the 
most well-known example. Buckminsterfullerene is composed of 60 or 70 carbon atoms shaped 
in a highly symmetrical spherical structure. Even though the substance in itself is unpatented, a 
huge number of patents have been issued on buckyball technology. From the classic buckyball 
shape the fullerene field has grown to a variety of carbon-based structures, including the above 
mentioned carbon nanotubes. The fullerenes are important, because unlike most carbon forms, 
they have the ability to enclose and incorporate other elements, including metals and noble 
gases. Thus fullerene structures have huge potential for manufacturing novel compounds and 
polymers for many different types of applications in a broad array of technology fields.43 
It has to be noted that patent laws prohibit the patenting of abstract ideas, thus preventing 
early-stage patenting of broad concepts. Dr. Zekos sees the danger in patenting nanotechnology, 
which is still in its embryonic form, being the possible patenting of merely science and abstract 
ideas belonging to humanity. As mentioned above, many of the most basic ideas in 
nanotechnology are indeed already patented or may end up being patented.44 The issue of 
broad claiming in nanotechnology patents is dealt with next. 
3.3 Broad claiming and the “land grab” mentality in nanotechnology 
Developing basic building blocks in nanotechnology is itself a complex and uncertain process 
and turning those building blocks into useable products takes considerable further research and 
time. Nanotechnology inventions require high investment in research and development. This 
and the long and doubtful process of innovating insinuate that nanotechnology patents should 
be reasonably broad, but not to the extent they prohibit further innovation.45 
The temptation of claiming broadly and so receiving an issued patent that covers much more 
than the actual invention is understandable. The patent “land-grab” mentality means that 
corporate entities (and other potential patentees) seek and carve out far-reaching patent rights. 
Patentees often use the expedient of using broad and ambiguous terms in their patent claims to 
broaden the scope of protection for their invention. In some cases the specific types of 
nanoparticles, like quantum dots or nanotubes, are ambiguously described in the written 
description section of the patent instead of the actual patent claims. As an example of non-
specific terminology is the use of the word “nanoparticle”: it could refer to any shape nano-scale 
particle. Patents using such ambiguous terms are often subjected to claim interpretation to 
determine their true scope. Claim terms should be construed by first referring to intrinsic 
 
42 Buckminsterfullerene is named after the geodesic architect Buckminster Fuller. The substance is affectionately 
named “Buckyballs”. 
43 Halluin & Westin 2004, p. 229–231. 
44 Zekos 2006, p. 310 and 361. 
45 Zekos 2006, p. 361. 
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evidence, which includes the claims, the specification, and the prosecution history of a patent 
application. If the intrinsic evidence is not enough to clear the meaning of a claim term, then 
extrinsic evidence, such as dictionaries and relevant technical treatises, may be consulted.46 
Of course, by claiming broadly and using ambiguous terms in their patent applications, 
applicants take the risk of negative claim interpretation. Broad claiming in nanotechnology has 
lead to growing uncertainty amongst researchers, developers, policy-makers and investors 
regarding who really owns what particular element of technology. With focused claim drafting 
the patent owners may find it easier to convince investors and acquiring companies, who are 
wary of broad and possibly overlapping patents, of the defensibility and validity of their 
patents.47 The far-reaching patent rights provided by early nanotechnology patents seem to 
overlap. This could lead to a vast amount of litigation in the future48. In the U.S., 
commentators blame the USPTO and its problems of the trend of uncertainty and patent 
overlaps49. The EPO and other patent authorities around the world face the same problems. 
3.4 The challenges patent authorities encounter in nanotechnology 
The amount of patent applications has surged, and the applications are more complex than 
ever. Distinctive to nanotechnology patent applications is that they are of multidisciplinary 
nature and their proper examination requires wide know-how of the examiners. 
In Europe, EPO’s workload has been said to have multiplied by 20 over the past 25 years. The 
patent filings have increased exponentially, but probably more problematic than that is the 
increase in the number of claims and pages in the average application. The average number of 
claims in an application has risen from 12 to 20 in two decades and the pages have increased 
over the same time period from 16 to 30. The applications especially in the fields of new 
technologies are increasingly complex and typically also have the most number of claims per 
application. The workload is only expected to increase in the future, mainly because of the 
improved integration of the European market for technology through the London Protocol or 
the European Patent Litigation Agreement, the potentially sharp increase in patent filings  
 
 
46 O’Neill et al. 2007, p. 30–33. 
47 O’Neill et al. 2007, p. 30, 39 
48 Litigation on overlapping patents in nanotechnology is not only a future scenario, but reality today (as shown on 
the before mentioned cases in this paper). The point is that the amount of litigation may grow, depending of 
course partly on the patent authorities’ choices and decisions made concerning nanotechnology patents and 
licensing now and in the future. 
49 O’Neill et al. 2007, p. 30. 
   12 
Nordic Journal of Commercial Law 
Special Edition 2011 
originating from fast developing countries and the arrival of new actors.50 The described 
development has lead to pressure to increase productivity of the examiners at the EPO. 
Basically increasing productivity in this case means that examiners are spending less time on 
each application and thus the quantity of issued patents increases at the cost of quality.51 
The EPO set up a Nanotechnology Working Group in 2003 to ensure that it was well-prepared 
for the impact of nanotechnology. The working group has called on internal and external 
expertise to develop a strategy for facing the patent challenges ahead. The most welcomed 
action taken by the EPO to tackle nanotechnology was the introduction of the "Y01N" tags to 
label nanotechnology in EPO databases. The interdisciplinary nature of nanotechnology made 
it difficult for anyone to retrieve existing patent documents and other literature on 
nanotechnology from the databases available before the new “Y01N” tags. The Y10N code is 
constantly updated and improved along with the progression of the technology.52 The tagging 
system used in EPO helps both inventors and patent examiners in their search for prior art. 
In the U.S. the USPTO has also improved the quality of examination of nanotechnology patent 
applications. The USPTO created a nanotechnology class53 to organize most nanotechnology 
subject matter in a logical manner. Even though this significantly aides the patent examiners in 
their prior art search, it is still difficult to find relevant prior art. The USPTO has also utilized a 
Nanotechnology Customer Partnership program to help identify sources of prior art and 
establish technical training programs for examiners.54 
Finding relevant prior art is in fact a very challenging task. Instrumental in examining prior art 
could be the Peer to Patent Project55. Noveck calls for creating a wiki-based “peer-review” system 
that will allow the expert community to provide relevant prior art for pending applications. The 
information would supplement the results found by the examiner and provided by the 
applicant. The system could response to difficulties third parties face in providing relevant prior 
 
50 For one more reason, see van Zeebroeck et al. 2008: “- - the size of patent applications is strongly affected by their 
geographical origin and technological area, with US drafting styles and biotechnologies leading the race. The 
strong effect of the filing route followed by applications prior to be filed at the EPO (and the well-known 
increasing success of the PCT option) suggests that the internationalization of patenting procedures and of 
technology markets encourages applicants to draft their applications only once according to the contingencies and 
modes of the largest market, namely the US, and to transfer their US-styled applications across the world, 
including the EPO.” 
51 LaFlame 2010, p. 630–632. 
52 Nanotechnology in European patents - challenge and opportunity (Available at http://www.epo.org/news-
issues/issues/nanotechnology.html) 
53 Class 977 contains 263 subclasses. Class 977 is a cross-reference classification, and prior to issuance a 
nanotechnology patent is first assigned a main classification in an area related to its specific technology, and then 
assigned a secondary nanotechnology classification to provide a supplemental search resource. 
54 Williamson & Carpenter 2010, p. 133. 
55 The Peer to Patent Project is based on Beth Noveck’s 2002 paper “Peer to Patent”: Collective Intelligence, Open 
Review and Patent Reform. 
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art to an examiner during patent examination, as well as the difficulties patent examiners face 
trying to take into account all relevant prior art. One advantage in this system is its cost-
effectiveness: instead of wasting a huge amount of money in litigation, “bad” patents will be 
ferreted out expeditiously and with minimal costs. The USPTO has adopted a pilot program 
utilizing this proposed system for reviewing applications for Technology Center 2100, the chief 
group for software patents. The program has already led to communal prior art submissions 
against many big companies, like Yahoo and General Electric.56 
Other issues complicating matters even more in both the U.S. and in Europe, are the facts that 
nanotechnology nomenclature is still quite diverse and nanotechnology standards are only 
beginning to be developed. Besides that, the patenting authorities employ thousands of people. 
The EPO is employing 7000 from over 30 countries57 and the USPTO employs nearly 10 00058. 
This makes it challenging to provide the same level of education to everyone and maintain 
uniform practices in policymaking concerning, for example, the broadness of patent claims. 
4 Challenges and approaches to possible solutions 
4.1 Challenges 
There are three main challenges in the field of nanotechnology: patent thickets caused by broad 
and overlapping patents, patent trolls and infringement actions. What makes infringement 
actions special in this field is the fact that when operating on such a small scale, detecting 
infringement activity is difficult.  
The consequence of broad and overlapping nanotechnology patents being first filed and then 
granted is a patent thicket. A patent thicket is an unintentional formation of overlapping 
patent rights that belong to different owners. Patent thickets require that those seeking to 
commercialize new technology obtain licenses from multiple patentees. Patent thickets have the 
potential of preventing all parties from making a product that encompasses numerous patented 
technologies.59 As said, patent thickets are unwanted, because they typically stifle competition 
in market and furthermore impede innovation.  
A nanotechnology advisory firm called LuxResearch consults clients for investment in 
nanotechnology. The firm has developed the LuxReport, a report on nanotechnology patents. 
The report analyzed over one thousand patents related to the building blocks of 
 
56 Duane 2008, p. 70–72. 
57 The EPO, available at http://www.epo.org/about-us/jobs/why/who.html. Accessed at 10.3.2010. 
58 The USPTO 2011-2015 Strategic Human Capital Plan, p.24. Available at http://www.uspto.gov/ 
about/stratplan/USPTO_2011-2015_Strategic_Human_Capital_Plan.pdf. Accessed at 10.3.2010. 
59 Paredes 2006, p. 492–493. 
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nanotechnology. The report stated that many of the issued patents overlap, to the extent of 
making a potential patent thicket.60 
Nanotechnology seems to follow similar paths to the radio industry in its infancy. The early 
years of radio industry in the 1920’s were privately funded and there was extensive patenting 
among a diverse group of unaffiliated private entities. The diverse group of investors, each of 
whom were keen on exploiting their patents for maximum advantage, owning the key patents 
in the industry lead to rife patent litigation and patent blocking. In cases where two patents, 
owned by competing entities, were essential to practice a particular innovation, the patent 
battles resulted in deadlock. Such situations also halted progress, because in the radio industry 
one innovation builds on others and the end product is the result of many related technologies. 
Despite the reluctance of cross-licensing between key position corporations, finally some cross-
licensing agreements on patents had to be arranged. It has been stated that the development in 
the radio industry was forestalled by an overarching unwillingness to cross-license patents, and 
it is hard to object to that statement.61 
In the radio industry the seminal inventions were privately funded and privately owned and 
had strong immaterial property protection. In comparison nanotechnology is both privately and 
publicly financed, but has likewise strong IP protection. As a result of the Bayh-Dole Act 
though, in U.S. the publicly funded nanotechnology research will end up privately owned. This 
means that nanotechnology industry is in fact in a very similar state as the radio industry once 
was.62  
The development of a nanotechnology patent thicket could impede the licensing process 
required for further innovation. In nanotechnology, like in the radio industry, it is often 
necessary to obtain licenses from many different patent owners to enable the production of new 
technology. The accumulated transaction costs of all the required licenses may become 
prohibitive for the licensee. It has been marked that, in the field of nanotechnology, patent 
holders are not likely to collaborate voluntarily in order to form patent pools and 
circumnavigate these patent thicket licensing problems. Most of the nanotechnology research is 
already funded, so the inventors don’t have the need to pool patents. They rather keep their 
patents and licenses exclusive in order to gain greater profits in the future. Other reasons are 
for example the fact that there has been little demonstrated need for pooling and 
nanotechnology as a multidisciplinary field makes it likely for researchers specializing in one 
area to find it difficult to compare the values of patents from other branches of science. In 
 
60 Paredes 2006, p. 491. 
61 Sabety 2005, p. 495–497 
62 Sabety 2005, p. 507. 
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addition to the above-mentioned, nanotechnology is still in its infancy and as such an uncertain 
investment for financiers.63 
Although thousands of nanotechnology patents have been issued and even more have entered 
the application process in the United States, there is still very little nanotechnology-specific 
infringement litigation that would have reached judgment. Especially in common law countries 
ample case law would provide useful guidelines on the validity of nanotechnology patents. 
Considering the pace of nanotechnology development and innovations, infringing patents and 
applications are bound to have come up, so why is there still no significant nanotechnology-
specific infringement case law? The obvious reason is the expense of litigation. Also many 
innovators are in a situation where they simply lack standing. This leads to those innovators 
attempting to license "bad" patents rather than contest them. One factor deterring patent 
litigation is the assumption of symmetry: if a competitor sues you for infringement you can sue 
them back.64 The following two examples will shed little light on this issue. 
In the U.S. the first nanotechnology patent case in federal circuit was the In re Kumar case. The 
central question in the case was the overlapping size of nanoparticles used in polishing 
applications. Although the court disposed of the case on procedural grounds, the unanimous 
opinion touches upon a number of important issues for future nanotech patent cases. Then 
again, this was not a case involving litigation between two companies regarding infringement of 
a nanotech patent, but rather a determination by the PTO.65 Another example of a 
nanotechnology specific patent litigation is Cabot Microelectronics’ decision to pursue legal action 
against DuPont Air Products NanoMaterials (DA NanoMaterials) and Korea's Cheil Industries:  
Cabot claimed DA NanoMaterials is manufacturing and marketing slurries that infringe 
on its patents. Cabot made this decision at the turn of year 2006/2007. After this a long 
process followed. DA NanoMaterials brought a non-infringement lawsuit against Cabot 
and both parties were to submit pretrial filings by January 15, 2010. Finally, a jury in the 
United States District Court for the District of Arizona rendered a verdict according to 
which DA NanoMaterials’ products do not infringe Cabot’s patents. 
Even without knowing the exact legal and other expenses both parties had to carry during 
litigation, the process was undoubtedly remarkably costly.66 
 
63 Tullis 2005, p. 295–297. 
64 Tullis 2005, p. 298–299. See also Lemley 2008, p. 615. 
65 Baluch et al. 2005, p. 342–344. 
66 Online news concerning the case are available at: http://www.nanotechbuzz.com/50226711/ 
cabot_alleges_nanotechnology_patent_infringement.php, http://www.azonano.com/news.asp?newsID=14832, 
http://www.azonano.com/news.asp?NewsID=15188 and http://www.azonano.com/news.asp?newsID=18478. 
Accessed at 7.4.2011. 
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Nanotechnology is a difficult branch of technology from patent owner’s and licensee’s point of 
view, when they are considering the policing and enforcing nanotechnology patent rights 
against possible infringers. The exceptionally small scale makes it hard to analyze, observe and 
police the infringing activity of nanotechnology. Furthermore, a vast number of new 
innovations and improvements to existing technology are occurring almost daily across multiple 
disciplines. Thus the nature of nanotechnology as a small-scale multidisciplinary branch of 
science makes it difficult to determine whether a third party is infringing.67 Zekos has stated 
that because of this difficulty, nanotechnology industry will follow the footsteps of 
biotechnology: to avoid a patent thicket at the research stage it will not limit the scope or 
issuance of patents, but merely ignore them.68 
As mentioned before, the patent authorities are having a hard time reviewing nanotechnology 
patent applications thoroughly, partly because of the amount of the applications and partly 
because of the multidisciplinary nature of nanotechnology. This results in “bad” patents being 
issued, which in turn leads to increased and costly litigation, a burden on invention because of 
fear of potential infringement, and the rise of patent trolls.69 
Patent trolls are companies or persons that use their patents against one or more alleged 
infringers in a manner considered unduly aggressive or opportunistic. Often these patent trolls 
have no intention of manufacturing or marketing the patented inventions themselves.  
Among some industry representatives universities are considered to be patent trolls: 
universities don’t need a license to other people’s patent rights and thus have no 
interest in cross-licensing, so they are only interested in money70.  
Related to patent trolls is the term warehousing. In other words, these companies warehouse 
patent rights to extract cash from others that are found to be infringing these rights. In some 
cases the mere threat of costly litigation results in payment of tribute. Part of the problem is the 
patents resulting from publicly funded research. Universities should avoid warehousing patent 
rights as an investment and instead use their patents that have resulted from publicly funded 
research as tools to provide a nascent company with a competitive position that can attract 
capital to build a business.71 
 
67 Sutton et al. 2009, p. 180. 
68 Zekos 2006, p. 363. 
69 Duane 2008, p. 67. 
70 Lemley 2008, p. 615–616. 
71 Sabety 2005, p. 509–510. See also Duane 2008, p. 68–69. 
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4.2 Possible solutions 
A resolution to patent thicket could be found in licensing, but it has been argued that limiting 
the scope of overlapping claims is at least equally important72. When considering licensing 
nanotechnology, probably most of the questions unique to nanotechnology are related to size, 
but what the licensees should consider more, is the intellectual property matters. 
In the nanotechnology context the licensees should investigate intellectual property matters in 
detail. Often licensees do a comprehensive market survey and financial analysis and investigate 
carefully the technical aspects of the subject of the license but do not give the intellectual 
property the attention it deserves. As mentioned before, nanotechnology is a field of broad and 
overlapping patents. That is why it is important to include into the licensing due diligence 
report a review of the quality of the patents, with extra attention to the scope of the claims and 
the possibility for competitors to design around the technology.73 
As mentioned, the development of nanotechnology patent thicket could impede the licensing 
process required for further innovation. At this point one option could be compulsory 
licensing. Compulsory licensing means that government forces the patent holder to grant use to 
the state or others. The TRIPS agreement74 sets out specific provisions that shall be followed if 
a compulsory license is issued, and the requirements of such issues. Article 31 of the TRIPS 
Agreement permits World Trade Organization members to grant compulsory patent licenses 
under the limited circumstances of national emergency, antitrust violations, and public 
noncommercial use.75  
On one hand, compulsory licensing can be seen as a solution to certain problems in the field of 
nanotechnology, but on the other hand it can also be seen as a scheme that stifles innovation 
and investment. The only two statutory compulsory licensing provisions in the U.S. are for 
inventions related to atomic energy and air pollution control76. Developing downstream 
products comprises high risks and development costs, which makes proper patent protection 
highly important for companies. One aspect of this is the venture capitalists’ eagerness to invest 
in start-up companies: it decreases if there’s a risk that government shatters the patent barriers 
that protect their investments. Another issue is the decrease of public disclosure of 
technological process, when companies rely rather on trade secrets than patents to protect their 
 
72 Burk and Lemley 2003, p. 1614. 
73 Shaddox 2006, p. 165–167. 
74 The Agreement on Trade-Related Aspects of Intellectual Property Rights 
75 Tullis 2005, p. 293–297 and 311. 
76 According to Lemley (2008), some have even suggested that all publicly funded research should be subject to 
compulsory licensing. The opinion reflects the fear that universities might treat their licensing offices as revenue 
generation devices, which might lead to university patent policies that are not often consonant with the ultimate 
public interest. 
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inventions.77 Compulsory licensing is widely criticized and rarely used and thus it may not be 
the answer to solving problems caused by the patent thicket in the field of nanotechnology.  
It has been argued that limiting the scope of overlapping claims are at least equally important as 
licensing when trying to find a resolution to patent thicket. One tool to narrow broad claims 
that comprise these overlapping patent rights could be the written description requirement. 
One purpose of written description requirement is to ensure that the inventor actually has 
invented what the patent application claims; to obtain a valid patent an applicant must include 
in his or her application a specification adequately disclosing the invention and how to make 
and use it. The requirement protects against overbroad claim amendments by requiring patent 
applicants to provide a description sufficient to show that they are in possession of the 
invention. Thus the written description requirement derives in part from considerations of 
patent breadth. The assessment whether the written description sufficiently supports a patent’s 
claims is made through the eyes of the POSITA. It is considered probable that the third parties 
are likely to perceive what the POSITA is likely to understand.78 
According to Paredes, the written description requirement can be used to prevent or even clear 
the patent thicket in nanotechnology. He states that “each legal principle under the written 
description requirement should be examined and applied appropriately to each nanomaterial 
with broad, overlapping patents”. Also the strong presumption of compliance with the written 
description requirement should be inapplicable to new technologies.79  
4.3 Recommendations 
As mentioned earlier, broad and overlapping patent claims lead to patent thickets and at worse 
to patent blocks, if patent owners are not willing to cooperate with others. To prevent possible 
deadlock situations, cross-licensing and patent pools should be used more in the field of 
nanotechnology. Patent owners and licensees should also cooperate more to prevent 
infringement actions.  
A cross license is an agreement between two or more parties that grants each the right to 
practice the other’s patents. Despite the fact that the term ‘cross licensing’ implies that neither 
party pays monetary royalties to the other party, cross licenses may or may not involve fixed fees 
or running royalties, which can run in one direction or in both. Cross licenses may also involve 
various geographic or field-of-use restrictions. It is common that cross licenses involve some but 
not all relevant patents held by either party.80 Parties are often symmetric in a sense that they 
 
77 Miller 2005, p. 79–80. 
78 Paredes 2006, p. 493–496. 
79 Paredes 2006, p. 512. 
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both are usually companies and have certain essential patents in a certain field of technology. 
This symmetry also means that usually when a competitor sues a company, the company can 
sue them back81. Universities, as mentioned before, don’t need a license to other parties’ 
patents due to research exemption. This has lead to some commercial parties claiming that 
universities are patent trolls who only want to gain profit by licensing their own patents. 
In certain situations cross-licensing is also a means to eliminate or at least minimize costly legal 
battles; cross-licensing can offer a viable alternative to litigation for companies whose 
technologies have an overlapping scope. Parties should be encouraged to grant cross licenses 
when in this situation of similar or overlapping scopes. Covenants not to sue in cross-license 
agreements can decrease the costs associated with fighting infringement suits. Cross-licensing 
may also be a feasible strategy for late-comers looking to enter a technical area where there are 
already existing players. Usually late-comers are in a defendant position because the existing 
players have the basic patent rights of the technical area in question. However, if a late-comer 
enters the market with a patent portfolio that fences in an existing player’s technology, the late-
comer may be able to force the existing player into a cross-license agreement in order to 
maintain its possibilities of expanding its technology outwards. The terms of a cross license in 
this situation may well be advantageous to the late-comer because of the late-comer’s superior 
bargaining rights. In nanotechnology these situations occur for example in the area of nanotube 
technology, which is an area currently experiencing increased cross-licensing.82 
By definition, a patent pool is a consortium of at least two companies agreeing to cross-license 
patents relating to a particular technology. Under a patent pool, an entire group of patents is 
licensed in a package, usually to anyone willing to pay the associated royalties. 83 Under a 
package license, two or more patent holders agree to the terms on which they will jointly license 
their complementary patents and divide up the proceeds. 
Patent pools are a form of self-regulation. Pooling patents has its pros and cons. Pros of self-
regulation are among other things the use of top-level expertise when making the regulation 
and also increased commitment to the regulation.  According to some studies the parties 
involved in making the rules of a regulation are usually more willing to accept and conform it. 
Self-regulation is also more adaptable and cost efficient than government based regulation. It is 
said that self-regulation improves the equality of private parties in comparison to government 
officials. The criticism of self-regulation sums up in its inefficiency, possibly low sanctioning 
and the rise of free rider mentality. It has also been stated that self-regulation concentrates on 
the private interest at the expense of the public interest.84  
 
81 Lemley 2008, p. 615. 
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Patent pools bind only their member patent owners and licensors. One of the most important 
provisions in patent pools is the obligation to license certain key patents to the pool. Pooling 
the building block patents of nanotechnology could lead to both increased licensing in the field 
and broader access to technology. Pooling is a good option when compared to compulsory 
licensing. Especially in the U.S. the government intervention is traditionally seen as detrimental 
to competition and to free market economy. The attitude towards compulsory licensing is not 
too approving in other parts of the world either. Self-regulation, such as patent pools, is said to 
restrain the authorities’ interference and to provide the rise of field-specific appreciation85. Thus 
patent pools could be one answer to dealing with the patent thicket problem. As mentioned 
many times above, nanotechnology is at its infancy. This basically means that the patent thicket 
will probably thicken and become a bigger issue in few years because of the vastly growing 
amount of patent applications in the field. Forming patent pools seems to be a rational measure 
to take to avoid, among others, government interference and costly infringement litigations. 
Noticing infringement in nanotechnology, as stated above, is quite challenging. Cooperation 
between licensor and the licensee is one means to increase possibilities of detecting 
infringement actions early on. Mutual cooperation provisions can facilitate some of the burden 
faced by licensors in enforcing and policing their patent rights. Mutual cooperation provisions 
demand that both parties to the agreement cooperate to protect each other’s patent rights. 
These provisions may require that both the licensor and the licensee participate in gathering 
evidence and pursuing court action in the event of infringement. This can lead to the 
identification of infringing activity early on, before any significant financial or other harm 
comes to either party. Furthermore, mutual cooperation in a patent infringement action can 
lead to better chances of success in proving cause of action.86 
5 Conclusion 
Nanotechnology is one of the rising fields in technology of our age. Its special characteristics are 
its size and multidisciplinary nature. Nanotechnology is still at its infancy and has huge 
potential. Some nanotech related inventions are already a part of our daily lives and in the 
future innovations of this field will become more and more frequently used in everyday life.  
Nanotechnology poses many questions. Nowadays it is clear that nanotechnology inventions are 
generally patentable. Patentability criteria apply to nanotechnology the same way as to 
innovations from other fields of technology. The most notable issue to consider in nanotech 
patent applications is often related to size: whether the innovation in question is novel and 
entails an inventive step compared to similar inventions that operate on a different size scale. It 
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is also clear that a naturally occurring substance or a new found property of such substance can 
not be patented as such, but products or processes that arise from human effort are inventions 
and thus patentable. 
The authorities in both Europe and the U.S. have faced same problems as the amount of 
patent applications filed in the field of nanotechnology has grown vastly. Measures, like 
creating a labeling system for nanotechnology inventions or educating the staff are taken, but 
there’s still more to do. The patent authorities should be encouraged to find and use new, 
innovative methods in examining patent applications. One example introduced in this paper is 
the Peer to Patent Project. As the wise men have said; problems can’t be solved using the same 
way of thinking used when they were created87. Noveck’s wiki-based “peer-review” system is a 
modern creation that would not have been feasible a few decades ago, but fits well in the 
information society of today. 
Problematic in nanotechnology patenting is the fact that so many overlapping patents have 
already issued and there are probably more to come. This forms an undesirable patent thicket. 
As possible solutions to problems caused by patent thicket and blocking patents, voluntary 
licensing, both in the form of simple cross-licensing and creating patent pools, are introduced. 
Patentees should be encouraged to license more and to cooperate more. Licensors and licensees 
should work together in order to stop infringement activity. 
It seems that there is no need to change patenting legislation because of nanotechnology. 
Patent laws offer enough room to patent nanotechnological inventions. In the future, and 
already today, more attention should be paid to the scope of claims in nanotechnology patent 
applications and creating nanotechnology standards as well as a clear nomenclature. 
  
 
87 A quote from Albert Einstein: "We can't solve problems by using the same kind of thinking we used when we 
created them." 
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